Peter Finan (Karus Therapeutics Ltd.)

Finan, Peter (Epidarex Capital 2014– Venture Partner + Karus Therapeutics 201410– Head of Biology before Novartis)

	Organisation	Epidarex Capital Partners LLC, UK Office Edinburgh
	Group	Epidarex Capital (Group)
	Product	PI3 kinase inhibitor
	Product 2	drug development

Record changed: 2021-10-22

Picture Berlin Partner Top News Healthtech Company Mika 650x200px

More documents for Peter Finan

[1] Topas Therapeutics GmbH. (4/4/17). "Press Release: Paul Sekhri Joins Topas Therapeutics as Chairman of the Board". Hamburg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)